Instrument Inactif

Communiqués Eidos Therapeutics, Inc.

Actions

EIDX

US28249H1041

Recherche biotechnologique et médicale

Communiqués

26/01/21	EIDOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles (form 8-K)	AQ
26/01/21	Eidos Therapeutics : BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.	AQ
20/01/21	EIDOS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
12/01/21	EIDOS THERAPEUTICS, INC. : Other Events (form 8-K)	AQ
29/10/20	EIDOS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
29/10/20	Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update	GL
29/10/20	Eidos Therapeutics : Reports Third Quarter 2020 Financial Results and Business Update	AQ
09/10/20	EIDOS THERAPEUTICS INVESTOR ALERT BY The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eidos Therapeutics, Inc. - EIDX	BU
07/10/20	EIDX INVESTIGATION – Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty	BU
07/10/20	EIDX INVESTIGATION – Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty	BU
07/10/20	EIDOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
05/10/20	EIDOS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
05/10/20	(EIDX) Alert: Johnson Fistel Investigates Proposed Sale of Eidos Therapeutics; Are Shareholders Getting a Fair Deal?	PR
05/10/20	Eidos Therapeutics : BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement	AQ
29/09/20	EIDOS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
10/08/20	Eidos Therapeutics : Appoints Industry Leaders with Significant Development and Commercial Expertise to Board of Directors	AQ
07/08/20	EIDOS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
07/08/20	Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors	GL
06/08/20	EIDOS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
06/08/20	Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update	GL
01/06/20	EIDOS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
11/05/20	Eidos Therapeutics : Reports First Quarter 2020 Financial Results and Business Update	AQ
08/05/20	EIDOS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
08/05/20	Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update	GL
24/03/20	EIDOS THERAPEUTICS, INC. : Other Events (form 8-K)	AQ